Literature DB >> 31144062

Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?

Bernhard Wernly1, Michael Lichtenauer1, David Erlinge2, Christian Jung3.   

Abstract

Entities:  

Year:  2019        PMID： 31144062     DOI： 10.1007/s00392-019-01496-w

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  10 in total

1.  Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors.

Authors:  Seung-Yul Lee; Myeong-Ki Hong; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Hyo-Soo Kim; Marco Valgimigli; Tullio Palmerini; Gregg W Stone
Journal:  Clin Res Cardiol       Date:  2016-09-08       Impact factor: 5.460

2.  Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Authors:  Renato D Lopes; Gretchen Heizer; Ronald Aronson; Amit N Vora; Tyler Massaro; Roxana Mehran; Shaun G Goodman; Stephan Windecker; Harald Darius; Jia Li; Oleg Averkov; M Cecilia Bahit; Otavio Berwanger; Andrzej Budaj; Ziad Hijazi; Alexander Parkhomenko; Peter Sinnaeve; Robert F Storey; Holger Thiele; Dragos Vinereanu; Christopher B Granger; John H Alexander
Journal:  N Engl J Med       Date:  2019-03-17       Impact factor: 91.245

3.  Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Authors:  Christopher P Cannon; Deepak L Bhatt; Jonas Oldgren; Gregory Y H Lip; Stephen G Ellis; Takeshi Kimura; Michael Maeng; Bela Merkely; Uwe Zeymer; Savion Gropper; Matias Nordaby; Eva Kleine; Ruth Harper; Jenny Manassie; James L Januzzi; Jurrien M Ten Berg; P Gabriel Steg; Stefan H Hohnloser
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

4.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.

Authors:  Willem J M Dewilde; Tom Oirbans; Freek W A Verheugt; Johannes C Kelder; Bart J G L De Smet; Jean-Paul Herrman; Tom Adriaenssens; Mathias Vrolix; Antonius A C M Heestermans; Marije M Vis; Jan G P Tijsen; Arnoud W van 't Hof; Jurriën M ten Berg
Journal:  Lancet       Date:  2013-02-13       Impact factor: 79.321

Review 5.  Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?

Authors:  D Duerschmied; J Brachmann; H Darius; N Frey; H A Katus; W Rottbauer; A Schäfer; H Thiele; C Bode; Uwe Zeymer
Journal:  Clin Res Cardiol       Date:  2018-04-20       Impact factor: 5.460

6.  Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

Authors:  Ilaria Cavallari; Giuseppe Patti
Journal:  Am J Cardiol       Date:  2017-12-25       Impact factor: 2.778

7.  Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.

Authors:  C Michael Gibson; Roxana Mehran; Christoph Bode; Jonathan Halperin; Freek W Verheugt; Peter Wildgoose; Mary Birmingham; Juliana Ianus; Paul Burton; Martin van Eickels; Serge Korjian; Yazan Daaboul; Gregory Y H Lip; Marc Cohen; Steen Husted; Eric D Peterson; Keith A Fox
Journal:  N Engl J Med       Date:  2016-11-14       Impact factor: 91.245

8.  Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.

Authors:  Pascal Vranckx; Marco Valgimigli; Peter Jüni; Christian Hamm; Philippe Gabriel Steg; Dik Heg; Gerrit Anne van Es; Eugene P McFadden; Yoshinobu Onuma; Cokky van Meijeren; Ply Chichareon; Edouard Benit; Helge Möllmann; Luc Janssens; Maurizio Ferrario; Aris Moschovitis; Aleksander Zurakowski; Marcello Dominici; Robert Jan Van Geuns; Kurt Huber; Ton Slagboom; Patrick W Serruys; Stephan Windecker
Journal:  Lancet       Date:  2018-08-27       Impact factor: 79.321

Review 9.  Meta-Analysis Comparing Dual Versus Single Antiplatelet Therapy in Combination With Antithrombotic Therapy in Patients With Atrial Fibrillation Who Underwent Percutaneous Coronary Intervention With Stent Implantation.

Authors:  Bowen Lou; Xiao Liang; Yue Wu; Yangyang Deng; Bo Zhou; Zuyi Yuan; Jianqing She
Journal:  Am J Cardiol       Date:  2018-05-15       Impact factor: 2.778

10.  Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Harsh B Golwala; Christopher P Cannon; Ph Gabriel Steg; Gheorghe Doros; Arman Qamar; Stephen G Ellis; Jonas Oldgren; Jurrien M Ten Berg; Takeshi Kimura; Stefan H Hohnloser; Gregory Y H Lip; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2018-05-14       Impact factor: 35.855
  10 in total
  2 in total

1.  Impella in cardiogenic shock following acute myocardial infarction: a systematic review and meta-analysis.

Authors:  Kris G Vargas; Bernhard Jäger; Christoph C Kaufmann; Andrea Biagioli; Stephan Watremez; Fernando Gatto; Cem Özbek; Amjad Razouk; Alexander Geppert; Kurt Huber
Journal:  Wien Klin Wochenschr       Date:  2020-07-20       Impact factor: 1.704

Review 2.  Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI.

Authors:  Andreas Schäfer; Ulrike Flierl; Johann Bauersachs
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.